Skip to main content

Table 3 Characteristics of each treatment group

From: The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial

 

All patients (n = 13a)

Placebo (n = 7)

IL-1Ra (n = 6)

Mean age (range) (years)

54 (40 to 69)

50 (42 to 61)

58 (40 to 69)

Male/female

3/10

1/6

2/4

WFNS grade

   

1

1

1

0

2

5

4

1

3

0

0

0

4

3

1

2

5

4

1

3

Fisher grade

   

3

3

2

1

4

10

5

5

Aneurysm location

   

Anterior circulation

9

5

4

Posterior circulation

4

2

2

  1. an = 13, as this includes all patients in whom an infusion was started. One patient did not complete the infusion; therefore analyses included only 12 patients. IL-1Ra, interleukin-1 receptor antagonist; WFNS, World Federation of Neurosurgical Societies.
Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094